355 related articles for article (PubMed ID: 27257086)
1. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
[TBL] [Abstract][Full Text] [Related]
2. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
[TBL] [Abstract][Full Text] [Related]
3. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
Shao YY; Liu TH; Lee YH; Hsu CH; Cheng AL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1336-41. PubMed ID: 26860846
[TBL] [Abstract][Full Text] [Related]
4. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
[TBL] [Abstract][Full Text] [Related]
6. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
[No Abstract] [Full Text] [Related]
7. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization.
Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H
Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763
[TBL] [Abstract][Full Text] [Related]
9. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
[TBL] [Abstract][Full Text] [Related]
11. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
[TBL] [Abstract][Full Text] [Related]
12. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
[TBL] [Abstract][Full Text] [Related]
13. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
[TBL] [Abstract][Full Text] [Related]
14. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686
[TBL] [Abstract][Full Text] [Related]
15. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma.
Na SK; Yim SY; Suh SJ; Jung YK; Kim JH; Seo YS; Yim HJ; Yeon JE; Byun KS; Um SH
J Surg Oncol; 2018 Apr; 117(5):912-921. PubMed ID: 29448306
[TBL] [Abstract][Full Text] [Related]
16. A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Edeline J; Blanc JF; Johnson P; Campillo-Gimenez B; Ross P; Ma YT; King J; Hubner RA; Sumpter K; Darby S; Evans J; Iwuji C; Swinson D; Collins P; Patel K; Muazzam I; Palmer DH; Meyer T
Liver Int; 2016 Dec; 36(12):1821-1828. PubMed ID: 27214151
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases.
Feng D; Wang M; Hu J; Li S; Zhao S; Li H; Liu L
Ann Transl Med; 2020 Apr; 8(8):553. PubMed ID: 32411776
[TBL] [Abstract][Full Text] [Related]
18. The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
Gkika E; Bettinger D; Krafft L; Schultheiss M; Neeff HP; Maruschke L; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
Strahlenther Onkol; 2018 May; 194(5):403-413. PubMed ID: 29322205
[TBL] [Abstract][Full Text] [Related]
19. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
Ho SY; Liu PH; Hsu CY; Chiou YY; Su CW; Lee YH; Huang YH; Lee FY; Hou MC; Huo TI
Sci Rep; 2018 Jan; 8(1):843. PubMed ID: 29339752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
